Coloplast A/S (CLPBY)
OTCMKTS · Delayed Price · Currency is USD
9.58
-0.06 (-0.62%)
May 22, 2025, 3:58 PM EDT

Coloplast Statistics

Total Valuation

Coloplast has a market cap or net worth of 21.70 billion. The enterprise value is 25.26 billion.

Market Cap 21.70B
Enterprise Value 25.26B

Important Dates

The last earnings date was Tuesday, May 6, 2025.

Earnings Date May 6, 2025
Ex-Dividend Date May 16, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +1.60%
Shares Change (QoQ) -0.04%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 142.57M

Valuation Ratios

The trailing PE ratio is 32.95 and the forward PE ratio is 26.83.

PE Ratio 32.95
Forward PE 26.83
PS Ratio 5.39
PB Ratio 8.84
P/TBV Ratio n/a
P/FCF Ratio 29.78
P/OCF Ratio 23.82
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.15, with an EV/FCF ratio of 34.66.

EV / Earnings 38.36
EV / Sales 6.01
EV / EBITDA 19.15
EV / EBIT 22.25
EV / FCF 34.66

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.43.

Current Ratio 0.95
Quick Ratio 0.57
Debt / Equity 1.43
Debt / EBITDA 2.78
Debt / FCF 4.82
Interest Coverage 9.07

Financial Efficiency

Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 11.45%.

Return on Equity (ROE) 27.42%
Return on Assets (ROA) 9.64%
Return on Invested Capital (ROIC) 11.45%
Return on Capital Employed (ROCE) 19.65%
Revenue Per Employee 240,552
Profits Per Employee 39,328
Employee Count 16,639
Asset Turnover 0.57
Inventory Turnover 2.45

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -23.58% in the last 52 weeks. The beta is 0.58, so Coloplast's price volatility has been lower than the market average.

Beta (5Y) 0.58
52-Week Price Change -23.58%
50-Day Moving Average 10.33
200-Day Moving Average 11.81
Relative Strength Index (RSI) 35.54
Average Volume (20 Days) 214,114

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Coloplast had revenue of 4.03 billion and earned 658.38 million in profits. Earnings per share was 2.92.

Revenue 4.03B
Gross Profit 2.72B
Operating Income 1.09B
Pretax Income 940.92M
Net Income 658.38M
EBITDA 1.22B
EBIT 1.09B
Earnings Per Share (EPS) 2.92
Full Income Statement

Balance Sheet

The company has 105.63 million in cash and 3.52 billion in debt, giving a net cash position of -3.41 billion.

Cash & Cash Equivalents 105.63M
Total Debt 3.52B
Net Cash -3.41B
Net Cash Per Share n/a
Equity (Book Value) 2.45B
Book Value Per Share 10.90
Working Capital -72.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 910.93 million and capital expenditures -182.27 million, giving a free cash flow of 728.65 million.

Operating Cash Flow 910.93M
Capital Expenditures -182.27M
Free Cash Flow 728.65M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 67.52%, with operating and profit margins of 26.99% and 16.35%.

Gross Margin 67.52%
Operating Margin 26.99%
Pretax Margin 23.36%
Profit Margin 16.35%
EBITDA Margin 30.33%
EBIT Margin 26.99%
FCF Margin 18.09%

Dividends & Yields

This stock pays an annual dividend of 0.19, which amounts to a dividend yield of 1.99%.

Dividend Per Share 0.19
Dividend Yield 1.99%
Dividend Growth (YoY) -0.93%
Years of Dividend Growth 2
Payout Ratio 109.07%
Buyback Yield -1.60%
Shareholder Yield 0.39%
Earnings Yield 3.03%
FCF Yield 3.36%
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Coloplast has an Altman Z-Score of 5.13.

Altman Z-Score 5.13
Piotroski F-Score n/a